Faecal calprotectin as an aid to the diagnosis of non-IgE mediated cow's milk protein allergy
详细信息    查看全文
文摘
The aim of the study was to assess the use of faecal calprotectin (FCP) in infants with signs and symptoms of non-IgE-mediated cow's milk protein allergy (CMA) for both diagnosis and prediction of clinical response at the time of withdrawal of milk proteins.

Patients and methods

A one year prospective study was conducted on 82 infants between 1 and 12 months of age in the Eastern area of Málaga-Axarquía, of whom 40 of them had been diagnosed with non-IgE-mediated CMA (with suggestive symptoms and positive response to milk withdrawal), 12 not diagnosed with CMA, and 30 of them were the control group. FCP was measured at three different times: time of diagnosis, and one and three months later. ANOVA for repeated measures, nominal logistic regression and ROC curves were prepared using the SPSS.20 package and Medcalc.

Results

Differences between diagnostic and control groups were assessed: there was a statistically significant relationship (P < .0001) between high FCP levels and infants suffering CMA, as well as the levels at time of diagnosis, 1 and 3 months (P < .001). A ROC curve was constructed between FCP levels and diagnosis of CMA, with 138 μg/g, with the best cut-off being with an area under the curve of 0.89. However, it is only 0.68 to predict a clinical response.

Conclusions

FCP levels lower than 138 μg/g could be useful to rule out non-IgE-mediated CMA diagnosis. Calprotectin is not a good test to predict clinical response to milk withdrawal.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700